Accelerate Diagnostics announces 1-for-10 reverse stock split

Accelerate Diagnostics announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective at 5:00 p.m. Eastern Time, on July 11, 2023. The company’s common stock will begin trading on a post-split basis at the market open on July 12, 2023, under the company’s existing trading symbol “AXDX“. The reverse stock split is part of the company’s plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.